Scinvivo

Scinvivo, based in Amsterdam, shows strong potential in the deep tech and health tech sectors with its innovative imaging catheters using optical coherence tomography (OCT). Scinvivo's technology provides precise imaging, enhancing cancer diagnosis and treatment compared to traditional methods like MRI, CT scans, or ultrasound. This addresses key issues such as delayed diagnosis and less effective treatments. With backing from Santec Corporation and NLC, Scinvivo is well-positioned to improve cancer treatment accuracy and effectiveness. Their B2B model allows integration with medical institutions and healthcare providers, potentially revolutionizing cancer care delivery.